These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2456071)

  • 1. [Various aspects and results of therapy with interferon].
    Niederle N
    Arzneimittelforschung; 1988 Mar; 38(3A):449-53. PubMed ID: 2456071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapy with interferon--1988.
    Figlin RA
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotherapy with interferon in hematologic malignancies.
    Roth MS; Foon KA
    Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotherapy in clinical practice.
    Figlin RA
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon therapy in hematologic neoplasms].
    Schwarzinger I; Bettelheim P; Lechner K
    Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of interferons in the treatment of cancer.
    Hansen RM; Borden EC
    Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alfa interferon: combinations with other antineoplastic modalities.
    Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):48-60. PubMed ID: 3296212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferons, a class of cytokines with a large therapeutic activity range].
    Billard C
    Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons in oncology.
    Woll PJ; Pettengell R
    Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limits of the use of interferons in the clinic].
    Ludwig CU
    Schweiz Med Wochenschr; 1989 Nov; 119(44):1539-43. PubMed ID: 2479977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on interferon in cancer therapy in Japan].
    Ohno R
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1194-202. PubMed ID: 2437862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
    Foon KA; Bunn PA
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
    Foon KA; Roth MS; Bunn PA
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological activity of the interferons in hematologic malignancies.
    Gutterman JU
    Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alpha interferons--new therapeutic modalities].
    Bajcetić M; Zigon N; Samardzić R; Beleslin DB
    Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferons. Treatment of malignant hemopathies with interferons].
    Guilhot F; Sadoun A; Delwail V
    Ann Med Interne (Paris); 1993; 144(8):548-56. PubMed ID: 7513980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic response modifiers: the interferon alfa experience.
    Koeller JM
    Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S11-5. PubMed ID: 2481396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.